Targeting mitochondrial function for the treatment of breast cancer

Cláudia M Deus1, Ana R Coelho, Teresa L Serafim

  • 1CNC - Center for Neuroscience & Cell Biology, University of Coimbra, UC Biotech Building, Biocant Park, 3060-197 Cantanhede, Portugal.

Insights

Targeting mitochondria in breast cancer offers a promising strategy by reactivating apoptosis. This review explores metabolic remodeling and mitochondrial alterations to develop targeted therapies that eliminate cancer cells while sparing healthy ones.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Breast cancer treatment often involves reactivating apoptosis, a programmed cell death pathway.
  • Mitochondria are crucial for cellular metabolism, homeostasis, and regulating cell death.
  • Tumor cells exhibit distinct metabolic remodeling and mitochondrial alterations.

Purpose of the Study:

  • To review strategies targeting metabolic and mitochondrial alterations in breast cancer.
  • To identify compounds and delivery systems for selective cancer cell death.
  • To discuss improvements in existing molecules and novel drug development for breast cancer mitochondria.

Main Methods:

  • Literature review of scientific articles and clinical studies.
  • Analysis of metabolic pathways and mitochondrial functions in breast cancer.
  • Evaluation of targeted therapeutic strategies and drug delivery systems.

Main Results:

  • Mitochondria-targeted therapies can induce apoptosis in breast cancer cells.
  • Specific metabolic vulnerabilities and mitochondrial defects in tumor cells can be exploited.
  • Development of novel drug candidates and optimization of existing molecules show promise.

Conclusions:

  • Targeting mitochondrial alterations is an effective strategy for breast cancer treatment.
  • Selective targeting ensures minimal toxicity to normal cells.
  • Further research into novel drug candidates can improve breast cancer therapy outcomes.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
6.9K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.3K